Implementation of novel methodology to study the anti-relapse potential of cannabidiol

实施新方法来研究大麻二酚的抗复发潜力

基本信息

  • 批准号:
    9318822
  • 负责人:
  • 金额:
    $ 17.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-01 至 2018-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This exploratory/developmental project is designed is to establish novel methodology as a research tool in the PI's laboratory to explore the neurobiological basis of intriguing preliminary findings that the phytocannabinoid cannabidiol (CBD) attenuates cocaine seeking with effects that significantly outlast treatment. A major factor contributing to the compulsive and chronically relapsing nature of cocaine addiction is drug desire elicited by environmental stimuli that have become conditioned to cocaine's subjective effects. In animals, the efficacy of these stimuli to elicit cocaine seeking perseverates over long periods of abstinence despite frequent exposure under non-reinforced conditions, reflective of the compulsive nature of cocaine addiction. In preliminary studies, CBD (the main non-psychoactive and non-addictive component of the cannabis sativa plant) significantly attenuated reinstatement in an animal model of perseverating, compulsive- like cocaine seeking, with effects that were still unabated six weeks after treatment termination. These findings suggest that CBD reverses neuroplasticity underlying cocaine craving and relapse beyond mere transient pharmacological amelioration of vulnerability to relapse. Insight into the mechanisms underlying these effects may therefore have major implications for treatment drug development and understanding of the neural and molecular basis of compulsive cocaine seeking. The objective of this proposal is to explore the neurobiological basis of CBD's lasting "anti-reinstatement" actions by exploiting recent advances in fluorescence-activated cell sorting (FACS) and associated methodologies. These advances, spearheaded by the Co-I, Dr. Hope, permit rapid high-throughput regionally specific identification ("neural mapping") of Fos-expressing neurons that encode specific behaviors while at the same time providing RNA in a rapid and quantitative manner to permit characterization of molecular alterations in "behaviorally activated" neurons from single rats. The research plan is to extend the exploration of CBD's long-lasting effects on responsiveness to cocaine cues and ensuing cocaine seeking at the behavioral level, and to establish FACS and associated methodologies in the lab to identify brain sites and gene expression linked to the lasting attenuation of cocaine seeking by CBD. The results are expected to provide essential insight into neural and molecular targets through which CBD exerts its actions and to lay the foundations for subsequent full-scale projects ranging from systematic investigation of causal roles of identified neural targets and gene expression changes in mediating CBD's interference with cocaine seeking, to utilization of FACS for the identification of key genes and their epigenetic regulatory mechanisms responsible for the persistence of CBD's actions, and thereby to reveal novel therapeutic targets for relapse prevention.
 描述(由应用程序提供):该探索性/发展项目旨在建立新方法作为PI实验室中的研究工具,以探索有趣的初步发现的神经生物学基础,即植物大麻素大麻二醇(CBD)减弱可卡因可与可卡因寻求相关的效果,这些效果显着估计了治疗的影响。可卡因成瘾的强迫性和长期复发性质的一个主要因素是由环境刺激引起的药物,这些药物已得到可卡因的主观影响。在动物中,这些刺激的有效性引起可卡因寻求持久的长期 节制时期尽管经常在非增强条件下暴露,反映了可卡因成瘾的强迫性质。在初步研究中,CBD(大麻sativa植物的主要非精神活性和非成分成分)在持续的,强迫性的可卡因寻求动物模型中显着减弱了恢复原状,其效果在治疗终止后六周仍未减弱。这些发现表明,CBD逆转了可卡因渴望和继电器的神经可塑性,超出了短暂的药物对缓解脆弱性的改善。因此,深入了解这些作用潜在的机制可能对治疗药物的开发以及对强迫性可卡因寻求的神经系统和分子基础的理解具有重大影响。该提案的目的是通过利用荧光激活的细胞分选(FACS)和相关方法的最新进展来探索CBD持久的“抗重新陈述”作用的神经生物学基础。这些进步以Co-I为首的Hope博士,允许对表达特定行为的表达FOS的神经元快速高通量区域特定的鉴定(“神经映射”),同时以快速和定量的方式提供RNA,以允许在“行为激活”的神经元中的分子变化中提供RNA。该研究计划是扩展对CBD对可卡因提示反应的长期影响,并确保在行为层面寻求可卡因的响应能力,并在实验室中建立FACS和相关方法,以识别与CBD对可卡因寻求的持久衰减有关的大脑位点和基因表达。 The results are expected to provide essential insight into neural and molecular targets through which CBD exerts its actions and to lay the foundations for subsequent sequence full-scale projects ranging from systematic investigation of causal roles of identified neural targets and gene expression changes in mediating CBD's interference with cocaine seeking, to utilization of FACS for the identification of key genes and their epigenetic regulatory mechanisms responsible for CBD行动的持久性,从而揭示了预防救济的新型治疗靶标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Friedbert Weiss其他文献

Friedbert Weiss的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Friedbert Weiss', 18)}}的其他基金

The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history
成瘾的阴暗面:环境调节对有成瘾史的受试者中乙醇负强化的意义
  • 批准号:
    10543983
  • 财政年份:
    2020
  • 资助金额:
    $ 17.33万
  • 项目类别:
The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history
成瘾的阴暗面:环境调节对有成瘾史的受试者中乙醇负强化的意义
  • 批准号:
    9884577
  • 财政年份:
    2020
  • 资助金额:
    $ 17.33万
  • 项目类别:
The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history
成瘾的阴暗面:环境调节对有成瘾史的受试者中乙醇负强化的意义
  • 批准号:
    10321914
  • 财政年份:
    2020
  • 资助金额:
    $ 17.33万
  • 项目类别:
The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history
成瘾的阴暗面:环境调节对有成瘾史的受试者中乙醇负强化的意义
  • 批准号:
    10077806
  • 财政年份:
    2020
  • 资助金额:
    $ 17.33万
  • 项目类别:
EtOH Seeking and Relapse: Therapeutic Potential of Transdermal Cannabidiol
乙醇寻找和复发:透皮大麻二酚的治疗潜力
  • 批准号:
    9429509
  • 财政年份:
    2017
  • 资助金额:
    $ 17.33万
  • 项目类别:
Cannabidiol: Lasting attenuation of ethanol seeking
大麻二酚:乙醇寻求的持久减弱
  • 批准号:
    9251208
  • 财政年份:
    2016
  • 资助金额:
    $ 17.33万
  • 项目类别:
Implementation of novel methodology to study the anti-relapse potential of cannabidiol
实施新方法来研究大麻二酚的抗复发潜力
  • 批准号:
    8926574
  • 财政年份:
    2015
  • 资助金额:
    $ 17.33万
  • 项目类别:
EtOH Seeking and Relapse: Therapeutic Potential of Transdermal Cannabidiol
乙醇寻找和复发:透皮大麻二酚的治疗潜力
  • 批准号:
    9011983
  • 财政年份:
    2014
  • 资助金额:
    $ 17.33万
  • 项目类别:
EtOH Seeking and Relapse: Therapeutic Potential of Transdermal Cannabidiol
乙醇寻找和复发:透皮大麻二酚的治疗潜力
  • 批准号:
    8624288
  • 财政年份:
    2014
  • 资助金额:
    $ 17.33万
  • 项目类别:
Significance of withdrawal-related learning in EtOH craving and relapse
戒断相关学习在乙醇渴望和复发中的意义
  • 批准号:
    8370400
  • 财政年份:
    2012
  • 资助金额:
    $ 17.33万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.
使用体内实时生物传感器评估旨在延长戒烟治疗效果的前药。
  • 批准号:
    10546293
  • 财政年份:
    2023
  • 资助金额:
    $ 17.33万
  • 项目类别:
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
通过监督药物逐渐减量和数字认知行为失眠治疗,加强初级保健中催眠药物的停药
  • 批准号:
    10736443
  • 财政年份:
    2023
  • 资助金额:
    $ 17.33万
  • 项目类别:
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
  • 批准号:
    10706874
  • 财政年份:
    2023
  • 资助金额:
    $ 17.33万
  • 项目类别:
Modular Virtual Reality Therapeutic for Opioid and Stimulant Use Disorders
针对阿片类药物和兴奋剂使用障碍的模块化虚拟现实治疗
  • 批准号:
    10784642
  • 财政年份:
    2023
  • 资助金额:
    $ 17.33万
  • 项目类别:
Long-acting injectable ketamine for improved substance use disorder (SUD) treatment without dissociative effects.
长效注射氯胺酮,用于改善物质使用障碍 (SUD) 治疗,且不会产生解离效应。
  • 批准号:
    10744308
  • 财政年份:
    2023
  • 资助金额:
    $ 17.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了